Gender Transitioning: Psychiatric Evaluation & Hormone Therapy

This lecture covers the basic principles of gender transitioning, focusing on gender dysphoria, the process of gender transitioning, and the role of psychiatric evaluation in hormone therapy. It also discusses the psychological and physiological effects of hormone therapy, the individualized approach to treatment, risks, side effects, and the importance of age considerations. Additionally, disparities in transgender healthcare worldwide are highlighted, emphasizing the need for improved access and understanding. The speakers provide insights into the evolving public opinion on transgender healthcare and offer guidance on respectful language use when referring to transgender individuals.

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related concepts (20)

BIO-450: Molecular endocrinology

We will define the concept of homeostasis and principles of hormone action and the molecular mechanisms underlying them. Interactions with the environment and pertinent public health issues will be an

Transgender health care includes the prevention, diagnosis and treatment of physical and mental health conditions, as well as sex reassignment therapies, for transgender individuals. A major component of transgender health care is gender-affirming care, the medical aspect of gender transition. Questions implicated in transgender health care include gender variance, sex reassignment therapy, health risks (in relation to violence and mental health), and access to healthcare for trans people in different countries around the world.

Gender dysphoria (GD) is the distress a person experiences due to a mismatch between their gender identitytheir personal sense of their own genderand their sex assigned at birth. Previously, the diagnostic label gender identity disorder (GID) was used, until it was eliminated in 2013 with the release of the diagnostic manual DSM-5 in favor of the current term. The condition was renamed to remove the stigma associated with the term disorder. People with gender dysphoria commonly identify as transgender.

A transgender person (often abbreviated to trans person) is someone whose gender identity differs from that typically associated with the sex they were assigned at birth. Many experience gender dysphoria, which they may seek to alleviate through transitioning, often adopting a different name and set of pronouns in the process. They may pursue gender affirming care such as hormone replacement therapy and various gender-affirming surgeries. Not all transgender people desire these treatments and others may be unable to access them for financial, medical or legal reasons.

Gender identity is the personal sense of one's own gender. Gender identity can correlate with a person's assigned sex or can differ from it. In most individuals, the various biological determinants of sex are congruent, and consistent with the individual's gender identity. Gender expression typically reflects a person's gender identity, but this is not always the case. While a person may express behaviors, attitudes, and appearances consistent with a particular gender role, such expression may not necessarily reflect their gender identity.

Transgender hormone therapy, also called hormone replacement therapy (HRT) or gender-affirming hormone therapy (GAHT), is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity. This form of hormone therapy is given as one of two types, based on whether the goal of treatment is masculinization or feminization: Masculinizing hormone therapy – for transgender men or transmasculine people; consists of androgens and antiestrogens.